Repligen Sweden AB
556869-0704ActiveInspiring advances in bioprocessing for biologic drug manufacturing.
Bioprocessing Solutions Providerrepligen.com
Yleiskatsaus
- 100–199
- Työntekijät
- 500–1000milj SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Jacob Johnson
Vice President, Investor Relations
@repligen.com
J. Christopher Love
Member, Scientific Advisory Board
Tony J. Hunt
Executive Chairman
Ralf Kuriyel
Senior Vice President, Research and Development
+33 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Repligen is a life sciences company dedicated to advancing bioprocessing technologies for the production of biologic drugs. Since its founding in 1981, the organization has focused on developing and commercializing high-value products and flexible solutions for biopharmaceutical manufacturers global...